Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care

Digestive and Liver Disease

Volumn 46, Issue 4, 2014, Pages 295-301

  Vajro, Pietro ^a   Ferrante, Lorenza ^b   Lenta, Selvaggia ^c   Mandato, Claudia ^c   Persico, Marcello ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

Author keywords

Adolescence; Adulthood; Hepatobiliary diseases; Hepatologist; Paediatrics; Transition care

Indexed keywords

ACTIVE IMMUNIZATION; ADULT; ADULT DISEASE; AUTOIMMUNE LIVER DISEASE; BILE DUCT ATRESIA; CHILDHOOD DISEASE; CHRONIC LIVER DISEASE; EDUCATION PROGRAM; GROWTH DISORDER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MEDICATION COMPLIANCE; NONALCOHOLIC FATTY LIVER; NUTRITIONAL REQUIREMENT; NUTRITIONAL SUPPORT; PEDIATRICIAN; PREGNANCY; PRIORITY JOURNAL; PSYCHOSOCIAL DEVELOPMENT; REVIEW; TRANSITION TO ADULT CARE; TREATMENT PLANNING; VIRUS HEPATITIS; WILSON DISEASE;

ADOLESCENCE; ADULTHOOD; HEPATOBILIARY DISEASES; HEPATOLOGIST; PAEDIATRICS; TRANSITION CARE;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ADULT; BILIARY ATRESIA; CAROLI DISEASE; CHILD; CHILD DEVELOPMENT; CHRONIC DISEASE; DISEASE MANAGEMENT; FATTY LIVER; HEPATITIS, AUTOIMMUNE; HEPATITIS, VIRAL, HUMAN; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MEDICATION ADHERENCE; REPRODUCTIVE HEALTH; TRANSITION TO ADULT CARE;

EID: 84895550848     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.10.018     Document Type: Review

References (97)

1. Bruha R., Marecek Z., Pospisilova L., et al. Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation. Liver International 2011, 31:83-91.
2. Shinkai M., Ohhama Y., Take H., et al. Long-term outcome of children with biliary atresia who were not transplanted after the Kasai operation: >20-year experience at a children's hospital. Journal of Pediatric Gastroenterology and Nutrition 2009, 48:443-450.
3. Radhakrishnan K.R., Alkhouri N., Worley S., et al. Autoimmune hepatitis in children - impact of cirrhosis at presentation on natural history and long-term outcome. Digestive and Liver Disease 2010, 42:724-728.
4. Feldstein A.E., Perrault J., El-Youssif M., et al. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 2003, 38:210-217.
5. Feldstein A.E., Charatcharoenwitthaya P., Treeprasertsuk S., et al. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009, 58:1538-1544.
6. Iorio R., Giannattasio A., Cirillo F., et al. Long-term outcome in children with chronic hepatitis B: a 24-year observation period. Clinical Infectious Diseases 2007, 45:943-949.
7. Rosen D.S. Transition from paediatric to adult-oriented health care for the adolescent with chronic illness or disability. Adolescent Medicine 1994, 5:241-248.
8. Peters A., Laffel L. Diabetes care for emerging adults: recommendations for transition from paediatric to adult diabetes care systems: a position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Paediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Paediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Paediatric Endocrine Society (formerly Lawson Wilkins Paediatric Endocrine Society). Diabetes Care 2011, 34:2477-2485. American Diabetes Association Transitions Working Group.
9. Flume P.A., Anderson D.L., Hardy K.K., et al. Transition programs in cystic fibrosis centers: perceptions of paediatric and adult program directors. Pediatric Pulmonology 2001, 31:443-450.
10. Tucker L.B., Cabral D.A. Transition of the adolescent patient with rheumatic disease: issues to consider. Rheumatic Diseases Clinics of North America 2007, 33:661-672.
11. El-Matary W. Transition of children with inflammatory bowel disease: big task, little evidence. World Journal of Gastroenterology 2009, 30:3744-3747.
12. Cameron J.S. The continued care of children with renal disease into adult life. Pediatric Nephrology 2001, 16:680-685.
13. Ling S.C. Congenital cholestatic syndromes: what happens when children grow up. Canadian Journal of Gastroenterology 2007, 21:743-751.
14. Suchy J.F., Sokol R.J., Balistreri W.F. Liver disease in children 2007, Cambridge University Press, New York. 3rd ed.
15. Rook M., Rosenthal P. Caring for adults with paediatric liver disease. Current Gastroenterology Reports 2009, 11:83-89.
16. McManus M., Fox H., O'Connor K., et al. Paediatric perspectives and practices on transitioning adolescents with special needs to adult health care. Fact Sheet No. 6 2008, National Alliance to Advance Adolescent Health, Washington, DC, Available at, [accessed 02.03.13]. http://www.thenationalliance.org/jan07/factsheet6.pdf.
17. Leyva-Vega M., Gerfen J., Thiel B.D., et al. Genomic alterations in biliary atresia suggest region of potential disease susceptibility in 2 q37.3. American Journal of Medical Genetics 2010, 152:886-895.
18. Vajro P., Couturier M., Lemonnier F., et al. Effects of postoperative cholestyramine and phenobarbital administration on bile flow restoration in infants with extrahepatic biliary atresia. Journal of Pediatric Surgery 1986, 21:362-365.
19. Vajro P., Celentano L., Manguso F., et al. Per-rectal portal scintigraphy is complementary to ultrasonography and endoscopy in the assessment of portal hypertension in children with chronic cholestasis. Journal of Nuclear Medicine 2004, 45:1705-1711.
20. Khalil B.A., Perera M.T., Mirza D.F. Clinical practice: management of biliary atresia. European Journal of Pediatrics 2010, 169:395-402.
21. Shneider B.L., Abel B., Haber B., et al. Portal hypertension in children and young adults with biliary atresia. Journal of Pediatric Gastroenterology and Nutrition 2012, 55:567-573.
22. Vajro P., Ferrante L., Paolella G. Alagille syndrome: an overview. Clinics and Research in Hepatology and Gastroenterology 2012, 36:275-277.
23. Kamath B.M., Bason L., Piccoli D.A., et al. Consequences of JAG1 mutations. Journal of Medical Genetics 2003, 40:891-895.
24. Kamath B.M., Spinner N.B., Emerick K.M., et al. Anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 2004, 109:1354-1358.
25. Jacquemin E. Progressive familial intrahepatic cholestasis. Clinics and Research in Hepatology and Gastroenterology 2012, 36(Suppl. 1):S26-S35.
26. Colombo C., Vajro P., Degiorgio D., et al. Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. Journal of Pediatric Gastroenterology and Nutrition 2011, 52:73-83.
27. De Ville de Goyet J., D'Ambrosio G., Grimaldi C. Surgical management of portal hypertension in children. Seminars in Pediatric Surgery 2012, 21:219-232.
28. McKiernan P. Metabolic liver disease. Clinics and Research in Hepatology and Gastroenterology 2012, 36:287-290.
29. Mitchell G.A., Grompe M., Lambert M., et al. Hypertyrosinemia. The metabolic and molecular bases of inherited disease 2001, 1777-1806. McGraw Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly (Eds.).
30. Elsas L.J. Galactosemia. GeneReviews Internet. Seattle (WA) 1993-2013, University of Washington, Seattle, Available from. 2000 February 4 [updated 26.10.10]. http://www.ncbi.nlm.nih.gov/books/NBK1518/, R.A. Pagon, M.P. Adam, T.D. Bird (Eds.).
31. Cross N.C., de Franchis R., Sebastio G., et al. Molecular analysis of aldolase B genes in hereditary fructose intolerance. Lancet 1990, 335:306-309.
32. Yasawy M.I., Folsch U.R., Schmidt W.E., et al. Adult hereditary fructose intolerance. World Gastroenterol 2009, 15:2412-2413.
33. Häberle J., Boddaert N., Burlina A., et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet Journal of Rare Diseases 2012, 7:32.
34. Chinnery P.F. Mitochondrial disorders overview. GeneReviews Internet 1993-2013, University of Washington, Seattle, WA, Available from. 2000 June 08 [updated 16.09.10]. http://www.ncbi.nlm.nih.gov/books/NBK1224/, R.A. Pagon, M.P. Adam, T.D. Bird (Eds.).
35. Perretti A., Crispino G., Marcantonio L., et al. Clinical utility of electrophysiological evaluation in Crigler-Najjar syndrome. Neuropaediatrics 2007, 38:173-178.
36. Weiss K.H. Wilson disease. GeneReviews Internet 1993-2013, University of Washington, Seattle, WA, Available at. 1999 October 22 [updated 16.05.13]. http://www.ncbi.nlm.nih.gov/books/NBK1512/, R.A. Pagon, M.P. Adam, T.D. Bird (Eds.).
37. Nicastro E., Ranucci G., Vajro P., et al. Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology 2010, 52:1948-1956.
38. Ferenci P., Czlonkowska A., Stremmel W., et al. EASL clinical practice guidelines: Wilson's disease. Journal of Hepatology 2012, 56:671-685.
39. Iorio R., D'Ambrosi M., Marcellini M., et al. Serum transaminases in children with Wilson's disease. Journal of Pediatric Gastroenterology and Nutrition 2004, 39:331-336.
40. Caprai S., Vajro P., Ventura A., et al. Autoimmune liver disease associated with celiac disease in childhood: a multicenter study. Clinical Gastroenterology and Hepatology 2008, 6:803-806.
41. Alvarez F., Berg P.A., Bianchi F.B., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. Journal of Hepatology 1999, 31:929-938.
42. Manns M.P., Czaja A.J., Gorham J.D., et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010, 51:2193-2213.
43. Vajro P., Paolella G. Autoimmune hepatitis: current knowledge. Clinics and Research in Hepatology and Gastroenterology 2012, 36:284-286.
44. Strassburg C.P., Manns M.P. Transition of care between paediatric and adult gastroenterology. Autoimmune hepatitis. Best Practice and Research Clinical Gastroenterology 2003, 17:291-306.
45. Vajro P., Lenta S., Socha P., et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. Journal of Pediatric Gastroenterology and Nutrition 2012, 54:700-713.
46. Cassiman D., Jaeken J. NASH may be trash. Gut 2008, 57:141-144.
47. Socha P., Horvath A., Vajro P., et al. Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review. Journal of Pediatric Gastroenterology and Nutrition 2009, 48:587-596.
48. Lavine J.E., Schwimmer J.B., Van Natta M.L., et al. Nonalcoholic steatohepatitis clinical research network. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. Journal of the American Medical Association 2001, 305:1659-1668.
49. Vajro P., Mandato C., Licenziati M.R., et al. Effects of Lactobacillus rhamnosus strain GG in paediatric obesity-related liver disease. Journal of Pediatric Gastroenterology and Nutrition 2011, 52:740-743.
50. Pardee P.E., Lavine J.E., Schwimmer J.B. Diagnosis and treatment of paediatric nonalcoholic steatohepatitis and the implications for bariatric surgery. Seminars in Pediatric Surgery 2009, 18:144-151.
51. Giacchino R., Zancan L., Vajro P., et al. Hepatitis B virus infection in native versus immigrant or adopted children in Italy following the compulsory vaccination. Infection 2001, 29:188-191.
52. Murray K.F., Szenborn L., Wysocki J., et al. Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B. Hepatology 2012, 56:2018-2026.
53. Kurbegov A.C., Sokol R.J. Hepatitis B therapy in children. Expert Review of Gastroenterology and Hepatology 2009, 3:39-49.
54. Mack C.L., Gonzalez-Peralta R.P., Gupta N., et al. NASPGHAN practice guidelines: diagnosis and management of hepatitis C infection in infants, children, and adolescents. Journal of Pediatric Gastroenterology and Nutrition 2012, 54:838-855.
55. Yousef Y., Beland K., Mas E., et al. Predictive factors of lamivudine treatment success in an hepatitis B virus-infected paediatric cohort: a 10-year study. Canadian Journal of Gastroenterology 2012, 26:429-435.
56. Sokal E.M., Paganelli M., Wirth S., et al. Consensus of an expert panel on behalf of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines. Journal of Hepatology 2013, 59:814-829.
57. Burra P. The adolescent and liver transplantation. Journal of Hepatology 2012, 56:714-722.
58. Kelly D.A., Bucuvalas J.C., Alonso E.M., et al. Long-term medical management of the paediatric patient after liver transplantation: 2013 practice guideline by the American Association for the study of liver diseases and the American Society of Transplantation. Liver Transplantation 2013, 19:798-825.
59. Dommergues J.P., Letierce A., Gravereau L., et al. Current lifestyle of young adults after liver transplantation during childhood. American Journal of Transplantation 2010, 10:1634-1642.
60. Fredericks E.M., Dore-Stites D., Lopez M.J., et al. Transition of paediatric liver transplant recipients to adult care: patient and parent perspectives. Pediatric Transplantation 2011, 15:414-424.
61. Annunziato R.A., Parkar S., Dugan C.A., et al. Brief report: deficits in health care management skills among adolescent and young adult liver transplant recipients transitioning to adult care settings. Journal of Pediatric Psychology 2011, 36:155-159.
62. Annunziato R.A., Emre S., Shneider B., et al. Adherence and medical outcomes in paediatric liver transplant recipients who transition to adult services. Pediatric Transplantation 2007, 11:608-614.
63. LaRosa C., Glah C., Baluarte H.J., et al. Solid-organ transplantation in childhood: transitioning to adult health care. Paediatrics 2011, 127:742-753.
64. Webb N., Harden P., Lewis C., et al. Building consensus on transition of transplant patients from paediatric to adult healthcare. Archives of Disease in Childhood 2010, 95:606-611.
65. Kaufman M., Shemesh E., Benton T. The adolescent transplant recipient. Pediatric Clinics of North America 2010, 57:575-592.
66. Gritti A., Sicca F., Di Sarno A.M., et al. Emotional and behavioral problems after paediatric liver transplantation: a quantitative assessment. Pediatric Transplantation 2006, 10:205-209.
67. Denny B., Beyerle K., Kienhuis M., et al. New insights into family functioning and quality of life after paediatric liver transplantation. Pediatric Transplantation 2012, 16:711-715.
68. Mohammad S., Hormaza L., Neighbors K., et al. Health status in young adults two decades after paediatric liver transplantation. American Journal of Transplantation 2012, 12:1486-1495.
69. Gritti A., Pisano S., Salvati T., et al. Health-related quality of life in paediatric liver transplanted patients compared with a chronic liver disease group. Italian Journal of Pediatrics 2013, 39:55.
70. Wolf J.L. Liver disease in pregnancy. Medical Clinics of North America 1996, 80:1167-1187.
71. Terrabuio D.R., Abrantes-Lemos C.P., Carrilho F.J., et al. Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes. Journal of Clinical Gastroenterology 2009, 43:350-356.
72. Buchel E., Van Steenbergen W., Nevens F., et al. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. American Journal of Gastroenterology 2002, 97:3160-3165.
73. Ecevit Ç., Ünal F., Baran M., et al. Parenthood in paediatric liver transplant patients. Pediatric Transplantation 2012, 16:346-349.
74. Spearman C.W., Goddard E., McCulloch M.I., et al. Pregnancy following liver transplantation during childhood and adolescence. Pediatric Transplantation 2011, 15:712-717.
75. Sasaki H., Nio M., Hayashi Y., et al. Problems during and after pregnancy in female patients with biliary atresia. Journal of Pediatric Surgery 2007, 42:1329-1332.
76. Dufernez F., Lachaux A., Chappuis P., et al. Wilson disease in offspring of affected patients: report of four French families. Clinics and Research in Hepatology and Gastroenterology 2013, 37:240-245.
77. Burra P., Germani G., Gnoato F., et al. Adherence in liver transplant recipients. Liver Transplantation 2011, 17:760-770.
78. Piering K., Arnon R., Miloh T.A., et al. Developmental and disease-related influences on self-management acquisition among paediatric liver transplant recipients. Pediatric Transplantation 2011, 15:819-826.
79. Wallis C. Transition of care in children with chronic disease. British Medical Journal 2007, 334:1231-1232.
80. Masełbas W., Chabik G., Członkowska A. Persistence with treatment in patients with Wilson disease. Neurologia i Neurochirurgia Polska 2010, 44:260-263.
81. Crowley I., Wolfe K., Lock M., et al. Improving the transition between paediatric and adult healthcare: a systematic review. Archives of Disease in Childhood 2011, 96:548-553.
82. Viner R. Transition from paediatric to adult care. Bridging the gaps or passing the buck?. Archives of Disease in Childhood 1999, 81:271-275.
83. Huang J.S., Tobin A., Tompane T. Clinicians poorly assess health literacy-related readiness for transition to adult care in adolescents with inflammatory bowel disease. Clinical Gastroenterology and Hepatology 2012, 10:626-632.
84. Supporting the health care transition from adolescence to adulthood in the medical home. Paediatrics 2011, 128:182-200. American, Academy of Paediatrics, American Academy of Family Physicians, and American College of Physicians, Transitions Clinical Report Authoring Group.
85. Gleeson H., McCartney S., Lidstone V. 'Everybody's business': transition and the role of adult physicians. Clinical Medicine 2012, 12:561-566.
86. Chicago (USA), May 8, 2011. DDW. NASPGHAN/AASLD Paediatric Hepatology grows up: transitioning paediatric liver disease patients to adult care clinical symposium. http://www.scribd.com/doc/54925750/Program-Book11.
87. Barcelona (Spain), April 21, 2012. EASL Symposia Parallel session & YI Forum. Growing up with liver disease. http://www2.kenes.com/liver-congress/scientific/Pages/Scientific%20Programme.aspx.
88. London (UK), May 8-11, 2013. 46th ESPGHAN Meeting. Symposia: Controversies in Hepatology: Transition Hepatology (Paediatric Hepatologist vs. Adult Hepatologist). http://www.espghan2013.org/docs/conference-files/espghan-a5-programme.
89. Bell L.E., Bartosh S.M., Davis C.L., et al. Adolescent transition to adult care in solid organ transplantation: a consensus conference report. American Journal of Transplantation 2008, 8:2230-2242.
90. Doug M., Adi Y., Williams J., et al. Transition to adult services for children and young people with palliative care needs: a systematic review. Archives of Disease in Childhood 2011, 96:78-84.
91. Reiss J.G., Gibson R.W., Walker L.R. Health care transition: youth, family and provider perspectives. Paediatrics 2005, 115:112-120.
92. Patel M.S., O'Hare K. Residency training in transition of youth with childhood-onset chronic disease. Paediatrics 2010, 126:S190-S193.
93. Mc Donagh J.E., Viner R.M. Lost in transition? Between paediatric and adult services. British Medical Journal 2006, 332:435.
94. Steinbeck K.S., Brodie L., Towns S.J. Transition in chronic illness: who is going where?. Journal of Paediatrics and Child Health 2008, 44:478-482.
95. Lerret S.M., Menendez J., Weckwerth J., et al. Essential components of transition to adult transplant services: the transplant coordinators' perspective. Progress in Transplantation 2012, 22:252-258.
96. ESPGHAN Working Groups. Hepatology: transition age. http://www.espghan2013.org/working-groups.
97. Kelly D. Pediatric liver disease in adults. In: Di Bisceglie AM, Martin P, editors. Syllabus of the AASLD postgraduate course - "new treatments in liver disease - a new era of diagnostics, therapeutics, and intervention in hepatology". Washington DC. November 1-2, 2013. p. 57-61. Available at. http://www.aasld.org/livermeeting/Documents/E-Pub%20Files/2013_PG_Syllabus_FINAL.pdf.